 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1po5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Structure of mammalian cytochrome p450 2b4
|
|
Structure:
|
 |
Cytochrome p450 2b4. Chain: a. Synonym: cypiib4, p450-lm2, isozyme 2, p450 type b0. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Oryctolagus cuniculus. Rabbit. Organism_taxid: 9986. Gene: 2b4. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.60Å
|
R-factor:
|
0.217
|
R-free:
|
0.289
|
|
|
Authors:
|
 |
E.E.Scott,Y.A.He,M.R.Wester,M.A.White,C.C.Chin,J.R.Halpert, E.F.Johnson,C.D.Stout
|
Key ref:
|
 |
E.E.Scott
et al.
(2003).
An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.
Proc Natl Acad Sci U S A,
100,
13196-13201.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Jun-03
|
Release date:
|
07-Oct-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
|
|
P00178
(CP2B4_RABIT) -
Cytochrome P450 2B4
|
|
|
|
Seq: Struc:
|
 |
 |
 |
491 a.a.
465 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.14.1
- Unspecific monooxygenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O
|
 |
 |
 |
 |
 |
RH
|
+
|
reduced flavoprotein
|
+
|
O(2)
|
=
|
ROH
|
+
|
oxidized flavoprotein
|
+
|
H(2)O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Heme-thiolate
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
4 terms
|
 |
|
Biological process
|
oxidation-reduction process
|
1 term
|
 |
|
Biochemical function
|
electron carrier activity
|
9 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
100:13196-13201
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.
|
|
E.E.Scott,
Y.A.He,
M.R.Wester,
M.A.White,
C.C.Chin,
J.R.Halpert,
E.F.Johnson,
C.D.Stout.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The xenobiotic metabolizing cytochromes P450 (P450s) are among the most
versatile biological catalysts known, but knowledge of the structural basis for
their broad substrate specificity has been limited. P450 2B4 has been frequently
used as an experimental model for biochemical and biophysical studies of these
membrane proteins. A 1.6-A crystal structure of P450 2B4 reveals a large open
cleft that extends from the protein surface directly to the heme iron between
the alpha-helical and beta-sheet domains without perturbing the overall P450
fold. This cleft is primarily formed by helices B' to C and F to G. The
conformation of these regions is dramatically different from that of the other
structurally defined mammalian P450, 2C5/3LVdH, in which the F to G and B' to C
regions encapsulate one side of the active site to produce a closed form of the
enzyme. The open conformation of 2B4 is trapped by reversible formation of a
homodimer in which the residues between helices F and G of one molecule
partially fill the open cleft of a symmetry-related molecule, and an
intermolecular coordinate bond occurs between H226 and the heme iron. This dimer
is observed both in solution and in the crystal. Differences between the
structures of 2C5 and 2B4 suggest that defined regions of xenobiotic
metabolizing P450s may adopt a substantial range of energetically accessible
conformations without perturbing the overall fold. This conformational
flexibility is likely to facilitate substrate access, metabolic versatility, and
product egress.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The 2B4 structure and comparison with 2C5. (A) P450
2B4 is oriented to view the large cleft from the protein surface
to the heme. The sequence can be traced starting at the blue N
terminus and ending at the red C terminus. (B and C) Comparison
of 2B4 (B) and 2C5/3LV (1N6B [PDB]
) (C) structures. Residues with the highest rms deviations
between the two structures include 2B4 residues 37-50 (helix A'
and adjacent residues, magenta), residues 92-140 (helix B C
terminus to helix D N terminus, blue), residues 206-250
(C-terminal turn of helix F through helix G, purple), residues
275-300 (loop between helices H and I encompassing a
three-residue insertion in 2B4 relative to 2C5 and N-terminal
half of helix I, orange), and 474-479 ( turn between L' and [3-2],
gray). Excluding these residues, the rms deviation of 324 C^
atoms between 2B4 and
2C5 is 1.08 Å. The heme group is shown as a stick figure,
and the iron is shown as a red sphere. N and C termini are
labeled. Unless otherwise noted, molecular figures were
generated by using PYMOL (28).
|
 |
Figure 2.
Fig. 2. Comparison of structural elements composing the 2B4
cleft. (A) Clefts in the mammalian 2B4 (green) and the bacterial
154C1 (PDB ID code 1GWI [PDB]
, blue) P450s are composed of similar structural elements. (B)
In 2B4 (green) helices, F' and G' flex away from the B' helix,
whereas in 2C5 (yellow), they extend to form the roof of the
active site. For clarity, only the regions including helices B
through D, F through G, and I are shown. The heme is shown as a
stick figure.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Ma,
S.G.Bell,
W.Yang,
Y.Hao,
N.H.Rees,
M.Bartlam,
W.Zhou,
L.L.Wong,
and
Z.Rao
(2011).
Structural Analysis of CYP101C1 from Novosphingobium aromaticivorans DSM12444.
|
| |
Chembiochem, 12,
88-99.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.Li,
J.Shen,
G.Liu,
Y.Tang,
and
T.Hoshino
(2011).
Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations.
|
| |
Proteins, 79,
271-281.
|
 |
|
|
|
|
 |
Y.T.Lee,
E.C.Glazer,
R.F.Wilson,
C.D.Stout,
and
D.B.Goodin
(2011).
Three clusters of conformational States in p450cam reveal a multistep pathway for closing of the substrate access channel .
|
| |
Biochemistry, 50,
693-703.
|
 |
|
|
|
|
 |
H.Ouellet,
J.B.Johnston,
and
P.R.Ortiz de Montellano
(2010).
The Mycobacterium tuberculosis cytochrome P450 system.
|
| |
Arch Biochem Biophys, 493,
82-95.
|
 |
|
|
|
|
 |
N.N.Bumpus,
and
P.F.Hollenberg
(2010).
Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interaction.
|
| |
J Inorg Biochem, 104,
485-488.
|
 |
|
|
|
|
 |
N.Shakunthala
(2010).
New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochrome.
|
| |
Expert Opin Drug Metab Toxicol, 6,
1.
|
 |
|
|
|
|
 |
O.Shoji,
T.Fujishiro,
S.Nagano,
S.Tanaka,
T.Hirose,
Y.Shiro,
and
Y.Watanabe
(2010).
Understanding substrate misrecognition of hydrogen peroxide dependent cytochrome P450 from Bacillus subtilis.
|
| |
J Biol Inorg Chem, 15,
1331-1339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.J.Unwalla,
J.B.Cross,
S.Salaniwal,
A.D.Shilling,
L.Leung,
J.Kao,
and
C.Humblet
(2010).
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.
|
| |
J Comput Aided Mol Des, 24,
237-256.
|
 |
|
|
|
|
 |
S.C.Gay,
M.B.Shah,
J.C.Talakad,
K.Maekawa,
A.G.Roberts,
P.R.Wilderman,
L.Sun,
J.Y.Yang,
S.C.Huelga,
W.X.Hong,
Q.Zhang,
C.D.Stout,
and
J.R.Halpert
(2010).
Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution.
|
| |
Mol Pharmacol, 77,
529-538.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.C.Pochapsky,
S.Kazanis,
and
M.Dang
(2010).
Conformational plasticity and structure/function relationships in cytochromes P450.
|
| |
Antioxid Redox Signal, 13,
1273-1296.
|
 |
|
|
|
|
 |
Y.T.Lee,
R.F.Wilson,
I.Rupniewski,
and
D.B.Goodin
(2010).
P450cam visits an open conformation in the absence of substrate.
|
| |
Biochemistry, 49,
3412-3419.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Fischer,
N.Enkler,
G.Neudert,
M.Bocola,
R.Sterner,
and
R.Merkl
(2009).
TransCent: computational enzyme design by transferring active sites and considering constraints relevant for catalysis.
|
| |
BMC Bioinformatics, 10,
54.
|
 |
|
|
|
|
 |
C.R.McCullough,
P.K.Pullela,
S.C.Im,
L.Waskell,
and
D.S.Sem
(2009).
(13)C-Methyl isocyanide as an NMR probe for cytochrome P450 active sites.
|
| |
J Biomol NMR, 43,
171-178.
|
 |
|
|
|
|
 |
D.Fishelovitch,
S.Shaik,
H.J.Wolfson,
and
R.Nussinov
(2009).
Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism.
|
| |
J Phys Chem B, 113,
13018-13025.
|
 |
|
|
|
|
 |
H.L.Lin,
H.Zhang,
K.R.Noon,
and
P.F.Hollenberg
(2009).
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.
|
| |
J Pharmacol Exp Ther, 331,
392-403.
|
 |
|
|
|
|
 |
H.Zhang,
C.Kenaan,
D.Hamdane,
G.H.Hoa,
and
P.F.Hollenberg
(2009).
Effect of conformational dynamics on substrate recognition and specificity as probed by the introduction of a de novo disulfide bond into cytochrome P450 2B1.
|
| |
J Biol Chem, 284,
25678-25686.
|
 |
|
|
|
|
 |
L.H.Xu,
S.Fushinobu,
H.Ikeda,
T.Wakagi,
and
H.Shoun
(2009).
Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.
|
| |
J Bacteriol, 191,
1211-1219.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Balaz
(2009).
Modeling kinetics of subcellular disposition of chemicals.
|
| |
Chem Rev, 109,
1793-1899.
|
 |
|
|
|
|
 |
S.C.Gay,
L.Sun,
K.Maekawa,
J.R.Halpert,
and
C.D.Stout
(2009).
Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning.
|
| |
Biochemistry, 48,
4762-4771.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Chavarria-Soley,
H.Sticht,
E.Aklillu,
M.Ingelman-Sundberg,
F.Pasutto,
A.Reis,
and
B.Rautenstrauss
(2008).
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme.
|
| |
Hum Mutat, 29,
1147-1153.
|
 |
|
|
|
|
 |
J.D.Maréchal,
C.A.Kemp,
G.C.Roberts,
M.J.Paine,
C.R.Wolf,
and
M.J.Sutcliffe
(2008).
Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.
|
| |
Br J Pharmacol, 153,
S82-S89.
|
 |
|
|
|
|
 |
K.N.Myasoedova
(2008).
New findings in studies of cytochromes P450.
|
| |
Biochemistry (Mosc), 73,
965-969.
|
 |
|
|
|
|
 |
L.Li,
Z.Chang,
Z.Pan,
Z.Q.Fu,
and
X.Wang
(2008).
Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase.
|
| |
Proc Natl Acad Sci U S A, 105,
13883-13888.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.A.White,
N.Mast,
I.Bjorkhem,
E.F.Johnson,
C.D.Stout,
and
I.A.Pikuleva
(2008).
Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1.
|
| |
Acta Crystallogr D Biol Crystallogr, 64,
487-495.
|
 |
|
|
|
|
 |
N.N.Bumpus,
and
P.F.Hollenberg
(2008).
Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.
|
| |
Mol Pharmacol, 74,
990-999.
|
 |
|
|
|
|
 |
N.Oezguen,
S.Kumar,
A.Hindupur,
W.Braun,
B.K.Muralidhara,
and
J.R.Halpert
(2008).
Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.
|
| |
J Biol Chem, 283,
21808-21816.
|
 |
|
|
|
|
 |
R.K.Hughes,
F.K.Yousafzai,
R.Ashton,
I.R.Chechetkin,
S.A.Fairhurst,
M.Hamberg,
and
R.Casey
(2008).
Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
|
| |
Proteins, 72,
1199-1211.
|
 |
|
|
|
|
 |
U.M.Kent,
C.Sridar,
G.Spahlinger,
and
P.F.Hollenberg
(2008).
Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.
|
| |
Chem Res Toxicol, 21,
1956-1963.
|
 |
|
|
|
|
 |
W.Li,
Y.Tang,
H.Liu,
J.Cheng,
W.Zhu,
and
H.Jiang
(2008).
Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
|
| |
Proteins, 71,
938-949.
|
 |
|
|
|
|
 |
Y.Ding,
W.H.Seufert,
Z.Q.Beck,
and
D.H.Sherman
(2008).
Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
|
| |
J Am Chem Soc, 130,
5492-5498.
|
 |
|
|
|
|
 |
Y.T.Meharenna,
K.E.Slessor,
S.M.Cavaignac,
T.L.Poulos,
and
J.J.De Voss
(2008).
The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in p450cin.
|
| |
J Biol Chem, 283,
10804-10812.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Wada,
M.Mitsuda,
Y.Ishihara,
M.Watanabe,
M.Iwasaki,
and
S.Asahi
(2008).
Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.
|
| |
J Biochem, 144,
323-333.
|
 |
|
|
|
|
 |
Z.Chang,
L.Li,
Z.Pan,
and
X.Wang
(2008).
Crystallization and preliminary X-ray analysis of allene oxide synthase, cytochrome P450 CYP74A2, from Parthenium argentatum.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
668-670.
|
 |
|
|
|
|
 |
A.Baradaran-Heravi,
R.Vakili,
T.Robins,
J.Carlsson,
N.Ghaemi,
A.A'rabi,
and
M.R.Abbaszadegan
(2007).
Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
|
| |
Clin Endocrinol (Oxf), 67,
335-341.
|
 |
|
|
|
|
 |
A.J.Annalora,
E.Bobrovnikov-Marjon,
R.Serda,
A.Pastuszyn,
S.E.Graham,
C.B.Marcus,
and
J.L.Omdahl
(2007).
Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.
|
| |
Arch Biochem Biophys, 460,
262-273.
|
 |
|
|
|
|
 |
A.W.Munro,
H.M.Girvan,
and
K.J.McLean
(2007).
Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily.
|
| |
Nat Prod Rep, 24,
585-609.
|
 |
|
|
|
|
 |
H.C.Yeh,
A.L.Tsai,
and
L.H.Wang
(2007).
Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases.
|
| |
Arch Biochem Biophys, 461,
159-168.
|
 |
|
|
|
|
 |
H.Fernando,
D.R.Davydov,
C.C.Chin,
and
J.R.Halpert
(2007).
Role of subunit interactions in P450 oligomers in the loss of homotropic cooperativity in the cytochrome P450 3A4 mutant L211F/D214E/F304W.
|
| |
Arch Biochem Biophys, 460,
129-140.
|
 |
|
|
|
|
 |
J.P.Harrelson,
K.R.Henne,
D.O.Alonso,
and
S.D.Nelson
(2007).
A comparison of substrate dynamics in human CYP2E1 and CYP2A6.
|
| |
Biochem Biophys Res Commun, 352,
843-849.
|
 |
|
|
|
|
 |
L.Sun,
C.S.Chen,
D.J.Waxman,
H.Liu,
J.R.Halpert,
and
S.Kumar
(2007).
Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.
|
| |
Arch Biochem Biophys, 458,
167-174.
|
 |
|
|
|
|
 |
P.Lafite,
F.André,
D.C.Zeldin,
P.M.Dansette,
and
D.Mansuy
(2007).
Unusual regioselectivity and active site topology of human cytochrome P450 2J2.
|
| |
Biochemistry, 46,
10237-10247.
|
 |
|
|
|
|
 |
S.G.Rupasinghe,
H.Duan,
H.L.Frericks Schmidt,
D.A.Berthold,
C.M.Rienstra,
and
M.A.Schuler
(2007).
High-yield expression and purification of isotopically labeled cytochrome P450 monooxygenases for solid-state NMR spectroscopy.
|
| |
Biochim Biophys Acta, 1768,
3061-3070.
|
 |
|
|
|
|
 |
S.L.Collom,
A.P.Jamakhandi,
A.J.Tackett,
A.Radominska-Pandya,
and
G.P.Miller
(2007).
CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling.
|
| |
Arch Biochem Biophys, 459,
59-69.
|
 |
|
|
|
|
 |
S.Sansen,
M.H.Hsu,
C.D.Stout,
and
E.F.Johnson
(2007).
Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.
|
| |
Arch Biochem Biophys, 464,
197-206.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.N.Tsalkova,
N.Y.Davydova,
J.R.Halpert,
and
D.R.Davydov
(2007).
Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.
|
| |
Biochemistry, 46,
106-119.
|
 |
|
|
|
|
 |
U.M.Zanger,
K.Klein,
T.Saussele,
J.Blievernicht,
M.H.Hofmann,
and
M.Schwab
(2007).
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.
|
| |
Pharmacogenomics, 8,
743-759.
|
 |
|
|
|
|
 |
Y.J.Jang,
E.Y.Cha,
W.Y.Kim,
S.W.Park,
J.H.Shon,
S.S.Lee,
and
J.G.Shin
(2007).
CYP2S1 gene polymorphisms in a Korean population.
|
| |
Ther Drug Monit, 29,
292-298.
|
 |
|
|
|
|
 |
Y.Zhao,
L.Sun,
B.K.Muralidhara,
S.Kumar,
M.A.White,
C.D.Stout,
and
J.R.Halpert
(2007).
Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4.
|
| |
Biochemistry, 46,
11559-11567.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.D.Favia,
A.Cavalli,
M.Masetti,
A.Carotti,
and
M.Recanatini
(2006).
Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.
|
| |
Proteins, 62,
1074-1087.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Seifert,
S.Tatzel,
R.D.Schmid,
and
J.Pleiss
(2006).
Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin.
|
| |
Proteins, 64,
147-155.
|
 |
|
|
|
|
 |
C.E.Hernandez,
S.Kumar,
H.Liu,
and
J.R.Halpert
(2006).
Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.
|
| |
Arch Biochem Biophys, 455,
61-67.
|
 |
|
|
|
|
 |
D.H.Sherman,
S.Li,
L.V.Yermalitskaya,
Y.Kim,
J.A.Smith,
M.R.Waterman,
and
L.M.Podust
(2006).
The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae.
|
| |
J Biol Chem, 281,
26289-26297.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Kim,
and
D.DellaPenna
(2006).
Defining the primary route for lutein synthesis in plants: the role of Arabidopsis carotenoid beta-ring hydroxylase CYP97A3.
|
| |
Proc Natl Acad Sci U S A, 103,
3474-3479.
|
 |
|
|
|
|
 |
J.T.Pearson,
J.J.Hill,
J.Swank,
N.Isoherranen,
K.L.Kunze,
and
W.M.Atkins
(2006).
Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.
|
| |
Biochemistry, 45,
6341-6353.
|
 |
|
|
|
|
 |
M.Barbaro,
L.Baldazzi,
A.Balsamo,
S.Lajic,
T.Robins,
L.Barp,
P.Pirazzoli,
E.Cacciari,
A.Cicognani,
and
A.Wedell
(2006).
Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.
|
| |
J Mol Med, 84,
521-528.
|
 |
|
|
|
|
 |
M.Ekroos,
and
T.Sjögren
(2006).
Structural basis for ligand promiscuity in cytochrome P450 3A4.
|
| |
Proc Natl Acad Sci U S A, 103,
13682-13687.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.J.de Groot
(2006).
Designing better drugs: predicting cytochrome P450 metabolism.
|
| |
Drug Discov Today, 11,
601-606.
|
 |
|
|
|
|
 |
M.S.Achary,
A.B.Reddy,
S.Chakrabarti,
S.G.Panicker,
A.K.Mandal,
N.Ahmed,
D.Balasubramanian,
S.E.Hasnain,
and
H.A.Nagarajaram
(2006).
Disease-causing mutations in proteins: structural analysis of the CYP1B1 mutations causing primary congenital glaucoma in humans.
|
| |
Biophys J, 91,
4329-4339.
|
 |
|
|
|
|
 |
N.V.Strushkevich,
I.N.Harnastai,
G.I.Lepesheva,
and
S.A.Usanov
(2006).
Role of C-terminal sequence of cytochrome P450scc in folding and functional activity.
|
| |
Biochemistry (Mosc), 71,
1027-1034.
|
 |
|
|
|
|
 |
T.Uno,
A.Nakao,
S.Masuda,
Y.Taniguchi,
K.Kanamaru,
H.Yamagata,
M.Nakamura,
H.Imaishi,
and
K.Oono
(2006).
Modification of small molecules by using cytochrome P450 expressed in Escherichia coli.
|
| |
J Ind Microbiol Biotechnol, 33,
1043-1050.
|
 |
|
|
|
|
 |
U.M.Kent,
H.L.Lin,
D.E.Mills,
K.A.Regal,
and
P.F.Hollenberg
(2006).
Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.
|
| |
Chem Res Toxicol, 19,
279-287.
|
 |
|
|
|
|
 |
E.E.Scott,
and
J.R.Halpert
(2005).
Structures of cytochrome P450 3A4.
|
| |
Trends Biochem Sci, 30,
5-7.
|
 |
|
|
|
|
 |
E.Hazai,
Z.Bikádi,
M.Simonyi,
and
D.Kupfer
(2005).
Association of cytochrome P450 enzymes is a determining factor in their catalytic activity.
|
| |
J Comput Aided Mol Des, 19,
271-285.
|
 |
|
|
|
|
 |
J.Bojunga,
C.Welsch,
I.Antes,
M.Albrecht,
T.Lengauer,
and
S.Zeuzem
(2005).
Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency.
|
| |
Hum Genet, 117,
558-564.
|
 |
|
|
|
|
 |
J.Mestres
(2005).
Structure conservation in cytochromes P450.
|
| |
Proteins, 58,
596-609.
|
 |
|
|
|
|
 |
M.J.Coon
(2005).
Cytochrome P450: nature's most versatile biological catalyst.
|
| |
Annu Rev Pharmacol Toxicol, 45,
1.
|
 |
|
|
|
|
 |
N.Bistolas,
U.Wollenberger,
C.Jung,
and
F.W.Scheller
(2005).
Cytochrome P450 biosensors-a review.
|
| |
Biosens Bioelectron, 20,
2408-2423.
|
 |
|
|
|
|
 |
S.S.Lee,
H.E.Jeong,
K.H.Liu,
J.Y.Ryu,
T.Moon,
C.N.Yoon,
S.J.Oh,
C.H.Yun,
and
J.G.Shin
(2005).
Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
|
| |
Pharmacogenet Genomics, 15,
105-113.
|
 |
|
|
|
|
 |
W.M.Atkins
(2005).
Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
|
| |
Annu Rev Pharmacol Toxicol, 45,
291-310.
|
 |
|
|
|
|
 |
W.M.Atkins
(2004).
Implications of the allosteric kinetics of cytochrome P450s.
|
| |
Drug Discov Today, 9,
478-484.
|
 |
|
|
|
|
 |
T.L.Poulos
(2003).
Cytochrome P450 flexibility.
|
| |
Proc Natl Acad Sci U S A, 100,
13121-13122.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|